TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 59 filers reported holding TANGO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,176,827 | +1109.9% | 193,324 | +256.7% | 0.00% | – |
Q2 2023 | $179,923 | -39.7% | 54,194 | -28.3% | 0.00% | – |
Q1 2023 | $298,583 | +42.4% | 75,591 | +161.4% | 0.00% | – |
Q4 2022 | $209,663 | +152.6% | 28,919 | +24.8% | 0.00% | – |
Q3 2022 | $83,000 | -1.2% | 23,166 | +25.7% | 0.00% | – |
Q2 2022 | $84,000 | -29.4% | 18,432 | +17.3% | 0.00% | – |
Q1 2022 | $119,000 | +24.0% | 15,715 | +77.8% | 0.00% | – |
Q4 2021 | $96,000 | +300.0% | 8,837 | +378.5% | 0.00% | – |
Q3 2021 | $24,000 | – | 1,847 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |